One platform. Three purpose-built products.
From biomarker discovery to clinical trials, life sciences leaders rely on Concentriq LS to fast-track breakthroughs and turn siloed pathology data into a competitive advantage.
Leading academic medical centers, health systems, and commercial labs leverage Concentriq AP’s advanced digitization and AI to go fully digital — and never look back.
FDA-cleared for primary diagnosis, Concentriq AP-Dx offers an intuitive experience for interpreting and managing cases, advancing both late-stage clinical trials and diagnostic workflows.
Concentriq is the most trusted enterprise digital pathology platform. Find out why.
Explore our solutions from discovery to diagnosis
Discover, develop, deliver — faster
Deploy our enterprise pathology platform, real-world data, and AI solutions across the R&D lifecycle to bring treatments to market faster and reach more patients worldwide.
Run a modern, more productive lab
Accelerate your shift to 100% digital diagnosis — improve diagnostic quality, increase efficiency, and position your lab for future growth.
Accelerate precision medicine with AI
From development tools to analysis applications, scientists and pathologists can build and deploy AI solutions that accelerate therapy development and deliver precision diagnostics.
Advance next-gen R&D with multimodal data
Leverage one of the world’s largest pathology databases to accelerate critical milestones from discovery to development and beyond with clinically relevant, structured RWD.
Visionaries trust our vision
Leaders like PathGroup partner with us to help them rewire pathology for precision medicine. They know that our approach to digital pathology and AI is the key to smart, scalable growth and better patient care.
“With Proscia, we are going 100% digital to accelerate growth, improve our pathologist experience, and open new data opportunities with leading pharmas and CROs.”
Dr. Derek Welch, MD, FCAP, Chief Medical Officer, PathGroup
More than 12,000 pathologists and scientists use our platform daily at diagnostic laboratories and life sciences organizations, including major CROs and 16 of the top 20 pharma leaders.
Proscia Leads The Way Forward in Digital Pathology
We’re proud to be recognized for these outstanding achievements as we advance our mission to change the way we fight diseases like cancer.
Latest News & Events
Webinar
Rewiring Drug Development: The Strategic Power of Pathology and AI for Biopharma R&D
Now Available On-Demand
Today’s biopharma leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. In this exclusive Drug Discovery World webinar, leaders from Proscia, Amgen, Owkin and Nucleai explore what the shift from analog to computational pathology means for biopharma R&D.
Webinar
Survey Insights on Pathology’s Transformation to AI and Precision Medicine from Laboratory Leadership
Aired July 16, 2025 | Watch On Demand
Watch a panel discussion about the state of digital pathology and AI with Proscia customers PathGroup, Cleveland Clinic, and Spectrum Healthcare Partners. Leaders from these innovative and forward-thinking laboratories discuss findings from a recent survey of 360+ laboratory professionals.
Press Release
Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine
Study Report
Rewiring Pathology for Precision Drug Discovery and Development: A scientific review of the evidence behind digital pathology and AI’s transformative role in biopharma R&D
Product Release Blog
New in Concentriq AP: Streamlined Consults, Personalized Worklists, Expanded DICOM Support, and More. Maximize your digital investment with pathologist-centered innovation.